{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:59:51Z","timestamp":1784563191174,"version":"3.55.0"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008444","name":"Parkinsonfonden","doi-asserted-by":"publisher","award":["PDF-IRG-1443"],"award-info":[{"award-number":["PDF-IRG-1443"]}],"id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001288","name":"Parkinson's Disease Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS110398"],"award-info":[{"award-number":["NS110398"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS090107"],"award-info":[{"award-number":["NS090107"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neurobiolaging.2025.02.003","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:22:06Z","timestamp":1739992926000},"page":"54-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Advancing age and sex modulate antidyskinetic efficacy of striatal CaV1.3 gene therapy in a rat model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"149","author":[{"given":"Margaret E.","family":"Caulfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly J.","family":"Vander Werp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Stancati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryl E.","family":"Sortwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivette M.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Kordower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8137-2310","authenticated-orcid":false,"given":"Kathy","family":"Steece-Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40738-020-00074-3","article-title":"Staging of the estrous cycle and induction of estrus in experimental rodents: an update","volume":"6","author":"Ajayi","year":"2020","journal-title":"Fertil. Res. Pr."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.02.003_bib2","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1210\/en.2014-1463","article-title":"Medial prefrontal cortical estradiol rapidly alters memory system bias in female rats: ultrastructural analysis reveals membrane-associated estrogen receptors as potential mediators","volume":"155","author":"Almey","year":"2014","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.02.003_bib3","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1210\/en.2012-1458","article-title":"Estrogen receptors are found in glia and at extranuclear neuronal sites in the dorsal striatum of female rats: evidence for cholinergic but not dopaminergic colocalization","volume":"153","author":"Almey","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yhbeh.2015.06.010","article-title":"Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females","volume":"74","author":"Almey","year":"2015","journal-title":"Horm. Behav."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.02.003_bib5","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/cne.25320","article-title":"Estrogen receptors observed at extranuclear neuronal sites and in glia in the nucleus accumbens core and shell of the female rat: Evidence for localization to catecholaminergic and GABAergic neurons","volume":"530","author":"Almey","year":"2022","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib6","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib7","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4939-3271-9_14","article-title":"Intraparenchymal Stereotaxic Delivery of rAAV and Special Considerations in Vector Handling","volume":"1382","author":"Benskey","year":"2016","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/hgtb.2015.117","article-title":"Continuous Collection of Adeno-Associated Virus from Producer Cell Medium Significantly Increases Total Viral Yield","volume":"27","author":"Benskey","year":"2016","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/B978-0-12-819410-2.00009-6","article-title":"Plasticity, genetics, and epigenetics in l-dopa-induced dyskinesias","volume":"184","author":"Bove","year":"2022","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib10","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1038\/s41467-020-19505-2","article-title":"The once and future gene therapy","volume":"11","author":"Bulaklak","year":"2020","journal-title":"Nat. Comm."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.02.003_bib11","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s13311-020-00940-4","article-title":"Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We","volume":"17","author":"Buttery","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib12","series-title":"Jorg Striessnig, editor. Handbook of Experimental Pharmacology (HEP, volume 279: Voltage-gated Ca2+ Channels: Pharmacology, Modulation and their Role in Human Disease)","first-page":"107","article-title":"The Role of Striatal Cav1.3 Calcium Channels in Therapeutics for Parkinson's Disease","author":"Caulfield","year":"2023"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib13","article-title":"Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease","volume":"176","author":"Caulfield","year":"2021","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106111","article-title":"Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age","author":"Caulfield","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106111","article-title":"Downregulation of striatal Ca(V)1.3 inhibits the escalation of levodopa-induced dyskinesia in male and female parkinsonian rats of advanced age","volume":"181","author":"Caulfield","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.02.003_bib16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/mds.27337","article-title":"Animal models of l-dopa-induced dyskinesia in Parkinson's disease","volume":"33","author":"Cenci","year":"2018","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.02.003_bib17","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/mds.27959","article-title":"Dyskinesia matters","volume":"35","author":"Cenci","year":"2020","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.02.003_bib18","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/mds.29518","article-title":"Post-Mortem Studies of Neurturin Gene Therapy for Parkinson's Disease: Two Subjects with 10 Years CERE120 Delivery","volume":"38","author":"Chu","year":"2023","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.02.003_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/mds.27037","article-title":"Aging and Parkinson's disease: Different sides of the same coin","volume":"32","author":"Collier","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/787451","article-title":"The \"gender factor\" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study","volume":"2015","author":"Colombo","year":"2015","journal-title":"Sci. World J."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.02.003_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1177\/0192623315570339","article-title":"Vaginal Cytology of the Laboratory Rat and Mouse: Review and Criteria for the Staging of the Estrous Cycle Using Stained Vaginal Smears","volume":"43","author":"Cora","year":"2015","journal-title":"Toxicol. Pathol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib22","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1056\/NEJM196907312810517","article-title":"L-dopa in parkinson's syndrome","volume":"281","author":"Cotzias","year":"1969","journal-title":"N. Engl. J. Med"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib23","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/REP-16-0117","article-title":"Ovarian function and reproductive senescence in the rat: role of ovarian sympathetic innervation","volume":"153","author":"Cruz","year":"2017","journal-title":"Reprod"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nn1632","article-title":"Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models","volume":"9","author":"Day","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41531-018-0069-x","article-title":"Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort","volume":"4","author":"Eusebi","year":"2018","journal-title":"NPJ Park. Dis."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib26","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/mds.26102","article-title":"The medical treatment of Parkinson disease from James Parkinson to George Cotzias","volume":"30","author":"Fahn","year":"2015","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mds.26122","article-title":"Levodopa: 50 years of a revolutionary drug for Parkinson disease","volume":"30","author":"Fahn","year":"2015","journal-title":"Mov. Disord."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.02.003_bib28","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.26139","article-title":"Zooming in on the small: the plasticity of striatal dendritic spines in L-DOPA-induced dyskinesia","volume":"30","author":"Fieblinger","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib29","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1038\/ncomms6316","article-title":"Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia","volume":"5","author":"Fieblinger","year":"2014","journal-title":"Nat. Comm."},{"issue":"10","key":"10.1016\/j.neurobiolaging.2025.02.003_bib30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/bph.16060","article-title":"Ca(v) 1.3-selective inhibitors of voltage-gated L-type Ca(2+) channels: Fact or (still) fiction?","volume":"180","author":"Filippini","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yfrne.2005.04.004","article-title":"Interaction of rapid signal transduction cascades and gene expression in mediating estrogen effects on memory over the life span","volume":"26","author":"Foster","year":"2005","journal-title":"Front Neuroendocr."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/NDT.S350939","article-title":"Role of Calcium Homeostasis in Alzheimer's Disease","volume":"18","author":"Ge","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"26","key":"10.1016\/j.neurobiolaging.2025.02.003_bib33","doi-asserted-by":"crossref","first-page":"8396","DOI":"10.1523\/JNEUROSCI.5582-08.2009","article-title":"Nonequilibrium calcium dynamics regulate the autonomous firing pattern of rat striatal cholinergic interneurons","volume":"29","author":"Goldberg","year":"2009","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0304-3940(92)90152-W","article-title":"Effect of estrogen and progesterone on L-dopa induced dyskinesia in MPTP-treated monkeys","volume":"135","author":"Gomez-Mancilla","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-4328(00)00260-6","article-title":"Modification of ion channels and calcium homeostasis of basal forebrain neurons during aging","volume":"115","author":"Griffith","year":"2000","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnana.2019.00093","article-title":"Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation","volume":"13","author":"Haery","year":"2019","journal-title":"Front Neuroanat."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.02.003_bib37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3233\/JPD-171134","article-title":"ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study","volume":"7","author":"Hauser","year":"2017","journal-title":"JPD"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.02.003_bib38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mds.26947","article-title":"Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease","volume":"32","author":"Hernandez","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharm. Rev."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2217\/nmt-2021-0051","article-title":"Levodopa-induced dyskinesia: a brief review of the ongoing clinical trials","volume":"12","author":"Huot","year":"2022","journal-title":"Neurodegener. Dis. Manag"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib41","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1038\/mtm.2015.36","article-title":"AAV9 supports wide-scale transduction of the CNS and TDP-43 disease modeling in adult rats","volume":"2","author":"Jackson","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib42","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.omtn.2017.06.011","article-title":"Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS","volume":"8","author":"Kanaan","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib43","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ncomms2149","article-title":"CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson's disease","volume":"3","author":"Kang","year":"2012","journal-title":"Nat. Comm."},{"issue":"11","key":"10.1016\/j.neurobiolaging.2025.02.003_bib44","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41592-023-02034-3","article-title":"Waxholm Space atlas of the rat brain: a 3D atlas supporting data analysis and integration","volume":"20","author":"Kleven","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.maturitas.2016.01.015","article-title":"Modeling menopause: The utility of rodents in translational behavioral endocrinology research","volume":"87","author":"Koebele","year":"2016","journal-title":"Maturitas"},{"issue":"10-11","key":"10.1016\/j.neurobiolaging.2025.02.003_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41434-023-00390-5","article-title":"Successes and challenges in clinical gene therapy","volume":"30","author":"Kohn","year":"2023","journal-title":"Gene Ther."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib47","article-title":"Modulation by Estradiol of L-Dopa-Induced Dyskinesia in a Rat Model of Post-Menopausal Hemiparkinsonism","volume":"12","author":"Kolmancic","year":"2022","journal-title":"Life (Basel)"},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.nbd.2004.07.005","article-title":"Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia","volume":"17","author":"Konradi","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3389\/fncel.2018.00492","article-title":"Biological Sex, Estradiol and Striatal Medium Spiny Neuron Physiology: A Mini-Review","volume":"12","author":"Krentzel","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.02.003_bib50","doi-asserted-by":"crossref","first-page":"A622","DOI":"10.1016\/j.jval.2013.08.1820","article-title":"Burden of L-Dopa-Induced Dyskinesia in Parkinson's Disease Patients (Pd-Lid) in France - the Lidia Study Economic Analysis (Levodopa Induced Dyskinesia Impact Evaluation)","volume":"16","author":"Kryskowiak","year":"2013","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.02.003_bib51","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mds.20360","article-title":"Levodopa-dyskinesia incidence by age of Parkinson's disease onset","volume":"20","author":"Kumar","year":"2005","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib52","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/mds.27360","article-title":"Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations","volume":"33","author":"Lang","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12791","article-title":"Deletion of the voltage-gated calcium channel, Ca(V) 1.3, causes deficits in motor performance and associative learning","volume":"21","author":"Lauffer","year":"2022","journal-title":"Genes Brain Behav."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/jmedgenet-2019-106283","article-title":"Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson's disease","volume":"57","author":"Leonard","year":"2020","journal-title":"J. Med. Genet"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib55","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pharmtox-010818-021214","article-title":"The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease","volume":"59","author":"Liss","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib56","doi-asserted-by":"crossref","first-page":"15055","DOI":"10.1038\/mtm.2015.55","article-title":"AAV9-mediated central nervous system-targeted gene delivery via cisterna magna route in mice","volume":"3","author":"Lukashchuk","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib57","article-title":"Age-Specific Adult Rat Brain MRI Templates and Tissue Probability Maps","volume":"15","author":"MacNicol","year":"2021","journal-title":"Front Neuroinform"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.02.003_bib58","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/M20-1023","article-title":"A Clinical Trial of Isradipine: What Went Wrong","volume":"172","author":"Maiti","year":"2020","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fncir.2019.00032","article-title":"A Novel Type of Neuron Within the Dorsal Striatum","volume":"13","author":"Mao","year":"2019","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-4-20","article-title":"Calcium signaling in neurodegeneration","volume":"4","author":"Marambaud","year":"2009","journal-title":"Mol. Neurodegener."},{"issue":"4-5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ceca.2007.04.015","article-title":"L-type calcium channels in adrenal chromaffin cells: role in pace-making and secretion","volume":"42","author":"Marcantoni","year":"2007","journal-title":"Cell Calcium"},{"issue":"4A","key":"10.1016\/j.neurobiolaging.2025.02.003_bib62","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S1519-69842002000400008","article-title":"Determination of the estrous cycle phases of rats: some helpful considerations","volume":"62","author":"Marcondes","year":"2002","journal-title":"Braz. J. Biol."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib63","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.nbd.2005.07.002","article-title":"Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats","volume":"21","author":"Maries","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib64","article-title":"Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification","volume":"67","author":"McLean","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.737291","article-title":"Contributions of Ca(V)1.3 Channels to Ca(2+) Current and Ca(2+)-Activated BK Current in the Suprachiasmatic Nucleus","volume":"12","author":"McNally","year":"2021","journal-title":"Front Physiol."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib66","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41582-019-0294-x","article-title":"Sex differences in movement disorders","volume":"16","author":"Meoni","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"20","key":"10.1016\/j.neurobiolaging.2025.02.003_bib67","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1113\/JP270678","article-title":"Rescuing cardiac automaticity in L-type Cav1.3 channelopathies and beyond","volume":"594","author":"Mesirca","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.expneurol.2013.01.024","article-title":"Modeling dyskinesia in animal models of Parkinson disease","volume":"256","author":"Morin","year":"2014","journal-title":"Exp. Neurol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib69","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/wnf.0b013e318050c9f9","article-title":"Hormonal replacement therapy in women with Parkinson disease and levodopa-induced dyskinesia: a crossover trial","volume":"30","author":"Nicoletti","year":"2007","journal-title":"Clin. Neuropharmacol."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib70","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1523\/JNEUROSCI.3327-04.2005","article-title":"G-protein-coupled receptor modulation of striatal CaV1.3 L-type Ca2+\u2009channels is dependent on a Shank-binding domain","volume":"25","author":"Olson","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib71","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","article-title":"The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease","volume":"8","author":"Pang","year":"2019","journal-title":"Transl. Neurodegener."},{"issue":"13","key":"10.1016\/j.neurobiolaging.2025.02.003_bib72","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/mds.25639","article-title":"Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD)","volume":"28","author":"Parkinson Study Group","year":"2013","journal-title":"Mov. Disord."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.02.003_bib73","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7326\/M19-2534","article-title":"Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial","volume":"172","author":"Parkinson Study Group","year":"2020","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib74","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuroscience.2021.05.026","article-title":"Mechanisms of Antiparkinsonian Anticholinergic Therapy Revisited","volume":"467","author":"Paz","year":"2021","journal-title":"Neurosci"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2022.01.022","article-title":"Immediate-release\/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies","volume":"96","author":"Rascol","year":"2022","journal-title":"Park. Relat. Disord."},{"issue":"100","key":"10.1016\/j.neurobiolaging.2025.02.003_bib76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","article-title":"Ageing and Parkinson's disease: why is advancing age the biggest risk factor?","volume":"14","author":"Reeve","year":"2014","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.neurobiolaging.2025.02.003_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12868-018-0441-0","article-title":"Calcium currents in striatal fast-spiking interneurons: dopaminergic modulation of Ca(V)1 channels","volume":"19","author":"Rendon-Ochoa","year":"2018","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4939-9065-8_6","article-title":"Multimodal Production of Adeno-Associated Virus","volume":"1937","author":"Sandoval","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.02.003_bib79","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.02.003_bib80","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.biopsych.2008.09.008","article-title":"Antagonizing L-type Ca2+\u2009channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia","volume":"65","author":"Schuster","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105686","article-title":"Striatal synaptic adaptations in Parkinson's disease","volume":"167","author":"Shen","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.646924","article-title":"Cellular Senescence in Brain Aging","volume":"13","author":"Sikora","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neurobiolaging.2025.02.003_bib83","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1460-9568.2010.07077.x","article-title":"Impact of dendritic spine preservation in medium spiny neurons on dopamine graft efficacy and the expression of dyskinesias in parkinsonian rats","volume":"31","author":"Soderstrom","year":"2010","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.neurobiolaging.2025.02.003_bib84","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.27695","article-title":"Genetic silencing of striatal CaV1.3 prevents and ameliorates levodopa dyskinesia","volume":"34","author":"Steece-Collier","year":"2019","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neurobiolaging.2025.02.003_bib85","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/mds.28850","article-title":"Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease","volume":"37","author":"Surmeier","year":"2022","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.neurobiolaging.2025.02.003_bib86","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/cne.24381","article-title":"Brain maps 4.0-Structure of the rat brain: An open access atlas with global nervous system nomenclature ontology and flatmaps","volume":"526","author":"Swanson","year":"2018","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib87","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnana.2010.00150","article-title":"Heterogeneity and diversity of striatal GABAergic interneurons","volume":"4","author":"Tepper","year":"2010","journal-title":"Front. Neuroanat."},{"issue":"7","key":"10.1016\/j.neurobiolaging.2025.02.003_bib88","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1007\/s12035-016-0045-6","article-title":"L-Type Calcium Channels Modulation by Estradiol","volume":"54","author":"Vega-Vela","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib89","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.51300","article-title":"Isradipine plasma pharmacokinetics and exposure-response in early Parkinson's disease","author":"Venuto","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neures.2014.09.002","article-title":"Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex","volume":"93","author":"Watakabe","year":"2015","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.neurobiolaging.2025.02.003_bib91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/3-211-32234-5_1","article-title":"Gene technology based therapies in the brain","volume":"31","author":"Wirth","year":"2006","journal-title":"Adv. Tech. Stand. Neurosurg."},{"issue":"16","key":"10.1016\/j.neurobiolaging.2025.02.003_bib92","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1523\/JNEUROSCI.21-16-05944.2001","article-title":"Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines","volume":"21","author":"Xu","year":"2001","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.neurobiolaging.2025.02.003_bib93","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneur.62.4.601","article-title":"Sex differences in clinical and genetic determinants of levodopa peak-dose dyskinesias in Parkinson disease: an exploratory study","volume":"62","author":"Zappia","year":"2005","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.neurobiolaging.2025.02.003_bib94","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1111\/j.1460-9568.2006.04734.x","article-title":"Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB","volume":"23","author":"Zhang","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"28","key":"10.1016\/j.neurobiolaging.2025.02.003_bib95","doi-asserted-by":"crossref","first-page":"11655","DOI":"10.1523\/JNEUROSCI.0288-13.2013","article-title":"Aberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapses","volume":"33","author":"Zhang","year":"2013","journal-title":"J. Neurosci."}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458025000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T17:05:27Z","timestamp":1777568727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458025000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":95,"alternative-id":["S0197458025000272"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.02.003","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing age and sex modulate antidyskinetic efficacy of striatal CaV1.3 gene therapy in a rat model of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2025.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}